MedTrace Logo

Effect of Transcranial NIR Light Upon Memory

NCT04568057 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-02-23

No results posted yet for this study

Summary

A double-blind placebo-controlled study evaluating the effect of 1068nm NIR trans-cranial phototherapy upon the cognitive function of healthy individuals between the age of 45 years and 80 years.

Conditions

  • Age-related Cognitive Decline

Interventions

DEVICE

NIR Transcranial phototherapy device

1068 nm NIR helmet

DEVICE

Placebo Transcranial Device

The placebo device looks like the active device.

Sponsors & Collaborators

  • Maculume Ltd.

    lead INDUSTRY

Principal Investigators

  • Gordon Dougal, MB ChB · Maculume Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04568057 on ClinicalTrials.gov